Genetic Engineering & Biotechnology NewsCRISPR Use Could Lead to "Organic" Gene Therapies for Blood DisordersGenetic Engineering & Biotechnology NewsThe team, led by University of New South Wales (UNSW) professor Merlin Crossley, Ph.D., has i… Continue reading
Hemophilia News TodayNew Method May Improve Delivery of Targeted Gene Therapies, Study ReportsHemophilia News TodayThe nanospears are guided remotely with a magnetic field to ensure delivery of the correct gene to specific cells. These nanospears can b… Continue reading
Medical XpressSolution to 50-year-old mystery could lead to gene therapy for common blood disordersMedical XpressThe research solves a 50-year-old mystery about how these mutations – which are naturally carried by a small percentage of people – operate… Continue reading
Only Certain Gynecologic Malignancies Benefit from ImmunotherapyCuretoday.comAs checkpoint inhibitors have changed the treatment landscape for many cancers, three specific biomarkers identified a subgroup of women with cervical and ovarian cancer tumor… Continue reading
Twist Bioscience Raises $50MGenomeWebNEW YORK (GenomeWeb) – Synthetic DNA provider Twist Bioscience announced today that it has closed a $50 million private placement. "We have used our proprietary DNA synthesis platform, which delivers precision … Continue reading
The Scientist |
USDA Will Not Regulate CRISPR-Edited Crops
The Scientist The US Department of Agriculture (USDA) will not regulate plants that have been modified through genome editing, according to statement released last week (March 28) by the agency. In the announcement, the USDA states that it won’t oversee the use of … |
The Scientist |
USDA Will Not Regulate CRISPR-Edited Crops
The Scientist The US Department of Agriculture (USDA) will not regulate plants that have been modified through genome editing, according to statement released last week (March 28) by the agency. In the announcement, the USDA states that it won’t oversee the use of … |